The Serogroup B Meningococcal Vaccine Information Statement (VIS) is now available. Please click here.

This VIS, which may be used for both Bexsero and Trumenba, is dated August 14, 2015, and may be used starting immediately.

NOTE: This VIS reflects recommendations that have been voted on by ACIP but have not yet been published, regarding use of the vaccine in healthy adolescents and young adults. These recommendations will not take effect until they are published in the MMWR, expected to occur in September. At the present time, ACIP recommendations apply only to people 10 years of age and older at increased risk for serogroup B infections.